ImprimisRx NJ recalls Timolol-Latanoprost (0.5/0.005%) ophthalmic drops, Compounded, 5 mL bottle, Imprimis Rx, Ledgewood, NJ.
- Recall date
- November 9, 2022
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0060-2023
- FDA classification
- Class II
- Brand / firm
- ImprimisRx NJ
- Sold / distributed
- Nationwide in the USA
Why it was recalled
Subpotent Drug: The batches contain less than 90% of the labeled amount of latanoprost.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Timolol-Latanoprost (0.5/0.005%) ophthalmic drops, Compounded, 5 mL bottle, Imprimis Rx, Ledgewood, NJ.
Get recall alerts
Free email alert whenever ImprimisRx NJ has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: ImprimisRx NJ